Use of levonorgestrel intrauterine system for medical indications in adolescents

Lisa L. Bayer; Paula J.Adams Hillard

doi:10.1016/j.jadohealth.2012.09.022

Use of levonorgestrel intrauterine system for medical indications in adolescents

Lisa L. Bayer, Paula J.Adams Hillard

Research output: Contribution to journal › Review article › peer-review

34 Scopus citations

Abstract

The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.

Original language	English (US)
Pages (from-to)	S54-S58
Journal	Journal of Adolescent Health
Volume	52
Issue number	4 SUPPL.
DOIs	https://doi.org/10.1016/j.jadohealth.2012.09.022
State	Published - Apr 2013
Externally published	Yes

Keywords

Adolescent
Intrauterine device
Levonorgestrel intrauterine system
Noncontraceptive benefit

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Public Health, Environmental and Occupational Health
Psychiatry and Mental health

Access to Document

10.1016/j.jadohealth.2012.09.022

Cite this

@article{4698dce785e246b9ae846a4d1cbc92ae,

title = "Use of levonorgestrel intrauterine system for medical indications in adolescents",

abstract = "The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.",

keywords = "Adolescent, Intrauterine device, Levonorgestrel intrauterine system, Noncontraceptive benefit",

author = "Bayer, {Lisa L.} and Hillard, {Paula J.Adams}",

year = "2013",

month = apr,

doi = "10.1016/j.jadohealth.2012.09.022",

language = "English (US)",

volume = "52",

pages = "S54--S58",

journal = "Journal of Adolescent Health",

issn = "1054-139X",

publisher = "Elsevier USA",

number = "4 SUPPL.",

}

TY - JOUR

T1 - Use of levonorgestrel intrauterine system for medical indications in adolescents

AU - Bayer, Lisa L.

AU - Hillard, Paula J.Adams

PY - 2013/4

Y1 - 2013/4

N2 - The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.

AB - The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.

KW - Adolescent

KW - Intrauterine device

KW - Levonorgestrel intrauterine system

KW - Noncontraceptive benefit

UR - http://www.scopus.com/inward/record.url?scp=84875448850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875448850&partnerID=8YFLogxK

U2 - 10.1016/j.jadohealth.2012.09.022

DO - 10.1016/j.jadohealth.2012.09.022

M3 - Review article

C2 - 23535058

AN - SCOPUS:84875448850

VL - 52

SP - S54-S58

JO - Journal of Adolescent Health

JF - Journal of Adolescent Health

SN - 1054-139X

IS - 4 SUPPL.

ER -

Use of levonorgestrel intrauterine system for medical indications in adolescents

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this